PL371297A1 - Metoda leczenia depresji związkami będacymi agonistami receptora delta - Google Patents

Metoda leczenia depresji związkami będacymi agonistami receptora delta

Info

Publication number
PL371297A1
PL371297A1 PL02371297A PL37129702A PL371297A1 PL 371297 A1 PL371297 A1 PL 371297A1 PL 02371297 A PL02371297 A PL 02371297A PL 37129702 A PL37129702 A PL 37129702A PL 371297 A1 PL371297 A1 PL 371297A1
Authority
PL
Poland
Prior art keywords
receptor agonist
treating depression
agonist compounds
delta receptor
delta
Prior art date
Application number
PL02371297A
Other languages
English (en)
Inventor
Kwen-Jen Chang
William Pendergast
J.Peter Gengo
Original Assignee
Ardent Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardent Pharmaceuticals, Inc. filed Critical Ardent Pharmaceuticals, Inc.
Publication of PL371297A1 publication Critical patent/PL371297A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL02371297A 2001-10-29 2002-10-29 Metoda leczenia depresji związkami będacymi agonistami receptora delta PL371297A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34008401P 2001-10-29 2001-10-29
US33788701P 2001-11-02 2001-11-02

Publications (1)

Publication Number Publication Date
PL371297A1 true PL371297A1 (pl) 2005-06-13

Family

ID=26990913

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02371297A PL371297A1 (pl) 2001-10-29 2002-10-29 Metoda leczenia depresji związkami będacymi agonistami receptora delta

Country Status (11)

Country Link
US (1) US7030124B2 (pl)
EP (1) EP1450807B1 (pl)
JP (1) JP4892654B2 (pl)
CN (1) CN1596113B (pl)
CA (1) CA2464471C (pl)
MX (1) MXPA04004059A (pl)
NO (1) NO20042257L (pl)
PL (1) PL371297A1 (pl)
RU (1) RU2314809C2 (pl)
TW (1) TW200300089A (pl)
WO (1) WO2003037342A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100885100B1 (ko) * 2001-05-18 2009-02-20 아스트라제네카 아베 4(페닐-피페라지닐-메틸)벤즈아미드 유도체 및 통증,불안증 또는 위장관 장애 치료를 위한 이들의 용도
US8476280B2 (en) * 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
SE0203300D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
US7314880B2 (en) * 2003-01-02 2008-01-01 Mount Cook Biosciences, Inc. Cardioprotective delta opioid receptor agonists and methods of using same
CN100549004C (zh) 2003-10-01 2009-10-14 阿得罗公司 螺环杂环衍生物及其应用方法
SE0401968D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
DK1781631T3 (da) * 2004-08-02 2012-05-14 Astrazeneca Ab Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
AU2006236622B2 (en) * 2005-04-14 2011-09-22 Versi Group Llc Compositions of novel opioid compounds and method of use thereof
TW200803856A (en) * 2005-09-02 2008-01-16 Mount Cook Biosciences Inc Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
KR20110018317A (ko) * 2008-05-20 2011-02-23 아스트라제네카 아베 불안성 주요 우울 장애의 치료 방법
CN103467460A (zh) * 2013-09-23 2013-12-25 昆明理工大学 一类含噻吩环和苄基的二芳基甲基哌嗪化合物及其应用
CN105646151B (zh) * 2016-02-26 2018-06-29 山西大学 一种炔类化合物及其制备方法和该化合物的用途
EP3436013A4 (en) 2016-03-31 2019-11-13 Versi Group, LLC COMPOSITIONS BASED ON OPIACE RECEPTOR DELTA / OPAACEOUS RECEPTOR DELTA OPTIONAL AGONIST, AND METHODS FOR TREATING PARKINSON'S DISEASE

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807858A (en) * 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
US5681830A (en) 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
US5985880A (en) * 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US20020052007A1 (en) * 1992-02-03 2002-05-02 Chang Kwen Jen Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
US5574159A (en) 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
IL110512A (en) 1993-07-30 1998-10-30 Delta Pharmaceuticals Inc History of diarylmethyl piperazine, their preparation and pharmaceutical preparations containing them
US6046200A (en) 1994-09-09 2000-04-04 The United States Of America As Represented By The Secretary Of The Army Compositions having neuroprotective and analgesic activity
SE9504661D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
GB9709972D0 (en) * 1997-05-19 1997-07-09 Pfizer Ltd Tetrazoles
GB9804734D0 (en) 1998-03-05 1998-04-29 Pfizer Ltd Compounds
SE9904673D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904674D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904675D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
GB0017256D0 (en) 2000-07-13 2000-08-30 Merck Sharp & Dohme Therapeutic agents
KR100885100B1 (ko) 2001-05-18 2009-02-20 아스트라제네카 아베 4(페닐-피페라지닐-메틸)벤즈아미드 유도체 및 통증,불안증 또는 위장관 장애 치료를 위한 이들의 용도

Also Published As

Publication number Publication date
RU2314809C2 (ru) 2008-01-20
RU2004115748A (ru) 2005-03-27
JP4892654B2 (ja) 2012-03-07
CN1596113B (zh) 2010-05-26
EP1450807A4 (en) 2008-06-25
US20030144299A1 (en) 2003-07-31
CA2464471A1 (en) 2003-05-08
MXPA04004059A (es) 2005-03-31
JP2005508363A (ja) 2005-03-31
CA2464471C (en) 2012-05-15
TW200300089A (en) 2003-05-16
EP1450807B1 (en) 2013-12-25
CN1596113A (zh) 2005-03-16
NO20042257L (no) 2004-06-24
US7030124B2 (en) 2006-04-18
WO2003037342A1 (en) 2003-05-08
EP1450807A1 (en) 2004-09-01

Similar Documents

Publication Publication Date Title
HK1076771A1 (en) Method for making an article of unitary construction
EP1450807A4 (en) PROCESS FOR TREATING DEPRESSION WITH DELTA RECEPTOR AGONIST COMPOUNDS
EP1405219A4 (en) METHOD AND DEVICES FOR BUSINESS APPLICATION INTEGRATION
PL357927A1 (en) Method of obtaining trimethylpropane
GB0128287D0 (en) Novel method and compounds
IL147695A0 (en) Method of treating certain cancers using an estrogen agonist/antagonist
HK1054605A1 (en) Method for use of stack
PL353299A1 (en) Method of obtaining unsaturated silico-organic compounds
IL146598A0 (en) Method for the preparation of aggregates
IL161073A0 (en) Composition and method for treating diabetes
EP1463820A4 (en) METHOD FOR SCREENING CONNECTIONS
AU2003214800A1 (en) Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
AU2002361357A8 (en) Method for monosulphonylation of an aminobenzofuran compound
GB2366639B (en) Method of comparing parts
PL352866A1 (en) Novel isoindoloindolone compounds, method of obtaining tehm and pharmacological compoistion containing such compounds
GB0113408D0 (en) Autocatalytic coating method
EP1347297A4 (en) METHOD OF RE-USING DNA IMMOBILIZATION SUBSTRATE
AU2002353369A8 (en) Anti-pirate method for the distribution of digital content
SG96641A1 (en) Method of electro-coating an article
AU2002352120A8 (en) Coating method
AU2002366272A8 (en) Edg-receptor agonist for the treatment of hypertension
HUP0401146A3 (en) Method for producing alkyl nitrites and alkyl dinitrites
HU0100572D0 (en) Method for elimination of graphiti from big surface
HU0100184V0 (en) Method for forming of smokingset
HUP0100382A2 (en) Method for determining dispersion of dimension of granules of polidisperse materials

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)